Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Assessment of cardiovascular risk using isoprostane biomarkers and COX-2 selective inhibitors

Assessment of cardiovascular risk using isoprostane biomarkers and COX-2 selective inhibitors

US Patent 7833795 · Granted Nov 16, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetranor PGDM: a biomarker of PGD2 synthesis in vivo2014
Targeting mPGES-1 as a treatment for inflammation which avoids cardiovascular ri2009
Compositions and methods for regulating circadian rhythms2006
Methods and compositions for determining lipid peroxidation levels in oxidant st2004